申请人:Astellas Pharma Inc.
公开号:EP2198858A1
公开(公告)日:2010-06-23
Providing an oral formulation of a macrolide compound where the dissolution of the macrolide compound is under sustained release; and a sustained-release formulation containing a composition in solid solution, where the macrolide compound is a fine powder.
提供一种大环内酯类化合物的口服制剂,其中大环内酯类化合物的溶解度处于持续释放状态;以及一种含有固溶体组合物的持续释放制剂,其中大环内酯类化合物为细粉。